Open Access

Erratum to: MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer

  • Jia Li1,
  • Xiangjie Kong1,
  • Junfeng Zhang1,
  • Qifeng Luo1,
  • Xiaoyu Li1 and
  • Lin Fang1Email author
Contributed equally
Cancer Cell International201313:17

DOI: 10.1186/1475-2867-13-17

Received: 20 February 2013

Accepted: 20 February 2013

Published: 21 February 2013

The Primary research to this article has been published in Cancer Cell International 2013 13:7

Correction

After publication of this article [1], the authors noted an error in Figure 1. The labelling of normal tissues and cancer tissues was inverted. Please see Figure 1 for the corrected version. The authors apologise for any inconvenience this has caused.
https://static-content.springer.com/image/art%3A10.1186%2F1475-2867-13-17/MediaObjects/12935_2013_Article_406_Fig1_HTML.jpg
Figure 1

miR-26b is relatively downregulated in breast cancer.

Notes

Declarations

Authors’ Affiliations

(1)
Department of Breast and Thyroid, Shanghai Tenth People’s Hospital

References

  1. Li J, Kong X, Zhang J, Luo Q, Li X, Fang L: MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer. Cancer Cell Int. 2013, 13: 7-10.1186/1475-2867-13-7.PubMed CentralView ArticlePubMed

Copyright

© Li et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement